TY - JOUR
T1 - When choosing statin therapy
T2 - The case for generics
AU - Green, Jonas B.
AU - Ross, Joseph S.
AU - Jackevicius, Cynthia A.
AU - Shah, Nilay D.
AU - Krumholz, Harlan M.
PY - 2013/1/11
Y1 - 2013/1/11
N2 - The development of 'Top 5' lists across specialties and at regular intervals can help to remind physicians that optimal care is often possible at a lower cost. For purposes of cardiovascular risk reduction, generic statins, or their brand equivalents if priced similarly, remain the appropriate choice for dyslipidemic patients initiating statin therapy. In this article, we review the evidence supporting the choice of generic statins.
AB - The development of 'Top 5' lists across specialties and at regular intervals can help to remind physicians that optimal care is often possible at a lower cost. For purposes of cardiovascular risk reduction, generic statins, or their brand equivalents if priced similarly, remain the appropriate choice for dyslipidemic patients initiating statin therapy. In this article, we review the evidence supporting the choice of generic statins.
UR - http://www.scopus.com/inward/record.url?scp=84874072096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874072096&partnerID=8YFLogxK
U2 - 10.1001/jamainternmed.2013.1529
DO - 10.1001/jamainternmed.2013.1529
M3 - Review article
C2 - 23303273
AN - SCOPUS:84874072096
SN - 2168-6106
VL - 173
SP - 229
EP - 232
JO - JAMA internal medicine
JF - JAMA internal medicine
IS - 3
ER -